Critic at Large

Our totally bogus case report swiftly passed muster, with only minor revisions requested.

Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.

Taking into account the interaction of nuclear and mitochondrial genes in birds holds the promise of more objectively defining what constitutes a species.

What can be done to lower development costs and drug prices?

Mitochondrial replacement therapy raises important societal and ethical concerns, but should be embraced for its utility in preventing disease.

This fundamental form of scientific communication is threatened by modern recording technology and researchers who refuse to adhere to an age-old ethical code. 

Sorting out which data sets are clinical-grade is key to helping patients.

No longer considered an inevitability, growing older should be and is being treated like a chronic condition. 

It’s time to accelerate the conversation about why the research community is still not diverse.

The modern human brain evolved in social and environmental settings very unlike today’s. Despite our cultural and technological progress, tribal instincts remain.

As international collaboration becomes increasingly common, researchers must work to limit their own biases and let cultural diversity enhance their work.

Studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.